Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 57 citing Marfella: The ubiquitin-proteasome system and inflammatory activity in diabetic atherosclerotic.... (0.12 sec) 

Inflammation in Diabetes Mellitus: Role of Peroxisome Proliferator-Activated …


P Libby, J Plutzky - The American Journal of Cardiology, 2007 - Elsevier
Patients with type 2 diabetes mellitus and/or the metabolic syndrome have considerable cardiovascular
risk. Treatment with 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors (statins) and
with antihypertensive and some antihyperglycemic agents reduces this risk, but residual ...
Cited by 60 - Related articles - All 32 versions

Peroxisome proliferator-activated receptor-{gamma}-mediated effects in the …

- ahajournals.org
SZ Duan, MG Usher, RM Mortensen - Circulation Research, 2008 - Am Heart Assoc
Peroxisome proliferator-activated receptor (PPAR)- is a nuclear receptor and transcription factor
in the steroid superfamily. PPAR- agonists, the thiazolidinediones, are clinically used to treat
type 2 diabetes. In addition to its function in adipogenesis and increasing insulin ...
Cited by 45 - Related articles - All 5 versions

The macrophage at the crossroads of insulin resistance and atherosclerosis

- ahajournals.org
CP Liang, S Han, T Senokuchi, AR Tall - Circulation research, 2007 - Am Heart Assoc
The macrophage has emerged as an important player in the pathogenesis of both atherosclerosis
and insulin resistance. Cross-talk between inflammatory macrophages and adipocytes may be
involved in insulin resistance in peripheral tissues. Defective insulin signaling in cells of ...
Cited by 43 - Related articles - All 6 versions

Do glucose and lipids exert independent effects on atherosclerotic lesion initiation …

- ahajournals.org
JE Kanter, F Johansson, RC LeBoeuf, KE … - Circulation research, 2007 - Am Heart Assoc
It is becoming increasingly clear that suboptimal blood glucose control results in adverse effects
on large blood vessels, thereby accelerating atherosclerosis and cardiovascular disease, manifested
as myocardial infarction, stroke, and peripheral vascular disease. Cardiovascular disease ...
Cited by 33 - Related articles - All 8 versions

Morning blood pressure surge as a destabilizing factor of atherosclerotic plaque: …

- ahajournals.org
R Marfella, M Siniscalchi, M Portoghese, C Di Filippo, F … - Hypertension, 2007 - Am Heart Assoc
Whether morning blood pressure surge influences the molecular mechanisms of plaque progression
toward instability is not known. Recently, we have demonstrated enhanced activity of the
ubiquitin–proteasome system in human plaques and evidenced that it is associated with ...
Cited by 25 - Related articles - All 5 versions

Proteasome-dependent degradation of guanosine 5'-triphosphate cyclohydrolase I …

- ahajournals.org
J Xu, Y Wu, P Song, M Zhang, S Wang, MH Zou - Circulation, 2007 - Am Heart Assoc
Methods and Results— Exposure of human umbilical vein endothelial cells to high glucose concentrations
(30 mmol/L D-glucose) but not to high osmotic conditions (25 mmol/L L-glucose plus 5
mmol/L D-glucose) significantly lowered the levels of both GTPCH protein and BH4. In ...
Cited by 21 - Related articles - All 5 versions

Oxidative stress as the leading cause of acute myocardial infarction in diabetics


C Di Filippo, S Cuzzocrea, F Rossi, R … - Cardiovascular drug …, 2006 - interscience.wiley.com
The risk factors, such as hypertension and metabolic syndrome, tend to promote heart
pathology. These risk factors can aggravate concomitant heart insults as well. Diabetes mellitus
represents one of the most important risk factors for the development of heart pathology. ...
Cited by 19 - Related articles - BL Direct - All 4 versions

Bioactive lipids in metabolic syndrome


K Nagao, T Yanagita - Progress in Lipid Research, 2008 - Elsevier
The metabolic syndrome is a cluster of metabolic disorders, such as abdominal obesity,
dyslipidemia, hypertension and impaired fasting glucose that contribute to increased cardiovascular
morbidity and mortality. Although the pathogenesis of metabolic syndrome is complicated ...
Cited by 16 - Related articles - All 4 versions

Optimizing cardiovascular outcomes in diabetes mellitus


BE Sobel - The American Journal of Medicine, 2007 - Elsevier
This article presents a series of take-home statements, compiled by a multidisciplinary steering
committee, concerning significant aspects of macrovascular disease in patients with diabetes
mellitus, including the extent of risk, pathogenetic mechanisms, and optimal management ...
Cited by 14 - Related articles - All 12 versions

Thiazolidinediones and their fluid-related adverse effects: facts, fiction and putative …


J Karalliedde, RE Buckingham - Drug Safety, 2007 - ingentaconnect.com
Thiazolidinediones (TZDs) or glitazones are agents that are widely used for the Abstract treatment
of type 2 diabetes mellitus. These drugs have a multitude of therapeutic effects including reduction
in insulin resistance and hyperglycaemia, anti-inflam- matory effects and amelioration of ...
Cited by 15 - Related articles - BL Direct - All 6 versions


Result Page: 

1

2

3

4

5

6

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google